Evidence map›Paper›PMID 35015575›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Risk-Adjusted Mortality Rates as a Quality Proxy Outperform Volume in Surgical Oncology-A New Perspective on Hospital Centralization Using National Population-Based Data.

Philip Baum, Jacopo Lenzi, Johannes Diers, Christoph Rust, Martin E Eichhorn, Samantha Taber, Christoph-Thomas Germer, Hauke Winter, Armin Wiegering

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Assessing quality of critical care during an ongoing health emergency-a novel approach to evaluate quality of care at Lebanese public ICUs during COVID-19.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2024
    Article
  10. Article
  11. Personalized Treatment for Patients With Lung Cancer.Deutsches Arzteblatt international · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Keeping a Safe Distance From Surgical Volume Standards.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Philip BaumDepartment of Thoracic Surgery, Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-1091-0548
Jacopo LenziDepartment of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.ORCID 0000-0003-2882-4223
Johannes DiersDepartment of General, Visceral, Transplant, Vascular and Pediatric Surgery, University Hospital Wuerzburg, Wuerzburg, Germany.ORCID 0000-0002-1928-7801
Christoph RustDepartment of Econometrics, University of Regensburg, Regensburg, Germany.ORCID 0000-0001-5079-9664
Martin E EichhornDepartment of Thoracic Surgery, Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany.
Samantha TaberDepartment of Thoracic Surgery, Heckeshorn Lung Clinic, HELIOS Klinikum Emil von Behring, Berlin, Germany.
Christoph-Thomas GermerDepartment of General, Visceral, Transplant, Vascular and Pediatric Surgery, University Hospital Wuerzburg, Wuerzburg, Germany.
Hauke WinterDepartment of Thoracic Surgery, Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany.
Armin WiegeringDepartment of General, Visceral, Transplant, Vascular and Pediatric Surgery, University Hospital Wuerzburg, Wuerzburg, Germany.ORCID 0000-0001-7777-0909

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDespite a long-known association between annual hospital volume and outcome, little progress has been made in shifting high-risk surgery to safer hospitals. This study investigates whether the risk-standardized mortality rate (RSMR) could serve as a stronger proxy for surgical quality than volume.

methodsWe included all patients who underwent complex oncologic surgeries in Germany between 2010 and 2018 for any of five major cancer types, splitting the data into training (2010-2015) and validation sets (2016-2018). For each surgical group, we calculated annual volume and RSMR quintiles in the training set and applied these thresholds to the validation set. We studied the overlap between the two systems, modeled a market exit of low-performing hospitals, and compared effectiveness and efficiency of volume- and RSMR-based rankings. We compared travel distance or time that would be required to reallocate patients to the nearest hospital with low-mortality ranking for the specific procedure.

resultsBetween 2016 and 2018, 158,079 patients were treated in 974 hospitals. At least 50% of high-volume hospitals were not ranked in the low-mortality group according to RSMR grouping. In an RSMR centralization model, an average of 32 patients undergoing complex oncologic surgery would need to relocate to a low-mortality hospital to save one life, whereas 47 would need to relocate to a high-volume hospital. Mean difference in travel times between the nearest hospital to the hospital that performed surgery ranged from 10 minutes for colorectal cancer to 24 minutes for pancreatic cancer. Centralization on the basis of RSMR compared with volume would ensure lower median travel times for all cancer types, and these times would be lower than those observed.

conclusionRSMR is a promising proxy for measuring surgical quality. It outperforms volume in effectiveness, efficiency, and hospital availability for patients.

Indexed as

NeoplasmsSurgical OncologyGermanyHospital MortalityHospitals, High-VolumeHumans

Identifiers

PMID35015575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.